Louisiana 2019 2019 Regular Session

Louisiana Senate Bill SB164 Engrossed / Bill

                    SLS 19RS-347	ENGROSSED
2019 Regular Session
SENATE BILL NO. 164
BY SENATOR MORRISH 
Prefiled pursuant to Article III, Section 2(A)(4)(b)(i) of the Constitution of Louisiana.
HEALTH/ACC INSURANCE.  Provides relative to the administration of prescription drug
benefits. (8/1/19)
1	AN ACT
2 To amend and reenact R.S. 22:1006.1(A) and 1053(D) and R.S. 44:4.1(B)(11) and R.S.
3 44:4.1(B)(11) as amended by Section 2 of Act 371 of the 2018 Regular Session, to
4 enact R.S. 22:1053(E) and (F), and Subpart P of Part III of Chapter 4 of Title 22 of
5 the Louisiana Revised Statutes of 1950, to be comprised of R.S. 22:1260.41 through
6 1260.46, and to repeal R.S. 22:1657 and R.S. 22:1657 as amended by Section 1 of
7 Act 371 of the 2018 Regular Session, relative to the administration of prescription
8 drug benefits; to provide for prior authorization; to provide for step therapy; to
9 provide for licensure of pharmacy benefit managers; to provide for prohibited
10 conduct; to provide for consumer access to information; to provide for an exception
11 to the Public Records Law; and to provide for related matters.
12 Be it enacted by the Legislature of Louisiana:
13 Section 1.  R.S. 22:1006.1(A) and 1053(D) are hereby amended and reenacted and
14 R.S. 22:1053(E) and (F) and Subpart P of Part III of Chapter 4 of Title 22 of the Louisiana
15 Revised Statutes of 1950, comprised of R.S. 22:1260.41 through 1260.46, are hereby enacted
16 to read as follows:
17 §1006.1. Prior authorization; forms required; criteria
Page 1 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 164
SLS 19RS-347	ENGROSSED
1	A. As used in this Section:
2	(1) "Health benefit plan", "plan", "benefit", or "health insurance coverage"
3 means services consisting of medical care, provided directly, through insurance or
4 reimbursement, or otherwise, and including items and services paid for as medical
5 care under any hospital or medical service policy or certificate, hospital or medical
6 service plan contract, preferred provider organization, or health maintenance
7 organization contract offered by a health insurance issuer that may or may not be
8 administered by a pharmacy benefit manager. However, excepted benefits are not
9 included as a "health benefit plan".
10	(2) "Health insurance issuer" means any an entity that offers health insurance
11 coverage through a plan, policy, or certificate of insurance subject to state law that
12 regulates the business of insurance. "Health insurance issuer" shall also include a
13 health maintenance organization, as defined and licensed pursuant to Subpart I of
14 Part I of Chapter 2 of this Title.
15	(3) "Prior authorization" shall mean means a utilization management
16 criterion utilized to seek permission or waiver of a drug to be covered under a health
17 benefit plan that provides prescription drug benefits.
18	(4) "Prior authorization form" shall mean means a single uniform
19 prescription drug prior authorization form used by all health insurance issuers,
20 including any health insurance issuer pharmacy benefit managers, for the purpose of
21 obtaining prior authorization.
22	*          *          *
23 §1053. Requirement for coverage of step therapy or fail first protocols
24	*          *          *
25	D. A group health plan shall not require a covered person to follow a
26 plan's step therapy protocol if the prescribed drug is on the plan's prescription
27 drug formulary and the patient has tried the step therapy required prescription
28 drug while under his current or previous health insurance or health benefit
29 plan, and the provider has submitted justification and supporting clinical
Page 2 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 164
SLS 19RS-347	ENGROSSED
1 documentation that such prescription drug was discontinued due to lack of
2 efficacy or effectiveness, diminished effect, or an adverse event.  Pharmacy drug
3 samples shall not be considered trial and failure of a preferred prescription
4 drug in lieu of trying the step therapy required prescription drug.
5	E. The provisions of this Section shall not be construed to prevent:
6	(1) A group health plan from requiring a patient to try a generic
7 equivalent of a prescription drug before providing coverage for the equivalent
8 brand-name prescription drug.
9	(2) A practitioner from prescribing a prescription drug that the
10 practitioner has determined to be medically necessary.
11	D.F. As used in this Section, a "health coverage plan" shall mean any
12 hospital, health, or medical expense insurance policy, hospital or medical service
13 contract, employee welfare benefit plan, contract or agreement with a health
14 maintenance organization or a preferred provider organization, health and accident
15 insurance policy, or any other insurance contract of this type, including a group
16 insurance plan and the Office of Group Benefits programs that may or may not be
17 administered by a pharmacy benefit manager.
18	*          *          *
19	SUBPART P. PHARMACY BENEF IT MANAGERS
20 §1260.41. Short title
21	This Subpart shall be known and may be cited as the "Louisiana
22 Pharmacy Benefit Manager Licensure and Regulation Act". This Subpart shall
23 not be construed to contain the exclusive laws regulating the business of
24 pharmacy benefit managers.
25 §1260.42. Findings and purpose
26	A. The legislature finds that it is necessary to establish standards and
27 criteria for the regulation and licensure of pharmacy benefit managers. For
28 purposes of this Subpart, "pharmacy benefit manager" shall have the same
29 meaning as defined in R.S. 22:1641(8).
Page 3 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 164
SLS 19RS-347	ENGROSSED
1	B. The purposes of this Subpart are:
2	(1) To promote, preserve, and protect the health, safety, and welfare of
3 the public through effective licensure and regulation of pharmacy benefit
4 managers.
5	(2) To provide for powers and duties of the commissioner of insurance.
6	(3) To provide for penalties and fines.
7 §1260.43. Pharmacy benefit manager; licensure
8	A. A person or organization shall not establish or operate as a pharmacy
9 benefit manager in this state for health benefit plans without obtaining a license
10 from the commissioner of insurance pursuant to R.S. 22:1651.
11	B. As a condition of licensure, each pharmacy benefit manager shall
12 obtain a surety bond of no less than one million dollars.
13 §1260.44. Enforcement
14	A. The commissioner of insurance shall have enforcement authority
15 relative to pharmacy benefit managers as provided for under this Title.
16	B. The commissioner may examine or audit the books and records of a
17 pharmacy benefit manager in accordance with R.S. 22:1981 et seq. All
18 information or data acquired during an examination conducted pursuant to this
19 Section shall be considered proprietary, confidential, and not subject to
20 disclosure pursuant to R.S. 44:1 et seq.
21 §1260.45. Pharmacy benefit manager; prohibited conduct
22	A. No pharmacy benefit manager or other entity that administers
23 prescription drug benefits in Louisiana shall prohibit, by contract, a pharmacy
24 or pharmacist from informing a patient of all relevant options when acquiring
25 their prescription medication, including but not limited to the cost and clinical
26 efficacy of a more affordable alternative if one is available and the ability to pay
27 cash if a cash payment for the same drug is less than an insurance copayment
28 or deductible payment amount.
29	B. Any provision of a contract that violates the provisions of this Section
Page 4 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 164
SLS 19RS-347	ENGROSSED
1 shall be unenforceable and shall be deemed an unfair or deceptive act and
2 practice pursuant to R.S. 22:1961 et seq.
3 §1260.46. Consumer access to information
4	A. Effective January 1, 2020, the commissioner of insurance shall
5 provide a dedicated location on the department's website for pharmacy benefit
6 manager information and links.
7	B. For each of a pharmacy benefit manager's contractual or other
8 relationships with a health benefit plan or health insurance issuer, the
9 pharmacy benefit manager shall provide the department with the health benefit
10 plan's formulary and provide timely notification of formulary changes and
11 product exclusions. The information provided pursuant to this Subsection shall
12 be made available in a centralized location on the department's website in a
13 format that allows for consumer access, including links to pharmacy benefit
14 manager websites.
15	*          *          *
16 Section 2.  R.S. 44:4.1(B)(11) is hereby amended and reenacted to read as follows:
17 §4.1. Exceptions
18	*          *          *
19	B. The legislature further recognizes that there exist exceptions, exemptions,
20 and limitations to the laws pertaining to public records throughout the revised
21 statutes and codes of this state. Therefore, the following exceptions, exemptions, and
22 limitations are hereby continued in effect by incorporation into this Chapter by
23 citation:
24	*          *          *
25	(11) R.S. 22:2, 14, 31, 42.1, 88, 244, 263, 265, 461, 550.7, 571, 572, 572.1,
26 574, 618, 639, 691.4, 691.5, 691.6, 691.7, 691.8, 691.9, 691.9.1, 691.10, 691.38,
27 691.56, 732, 752, 753, 771, 834, 972(D), 976, 1008, 1019.2, 1203, 1260.44, 1460,
28 1464, 1466, 1488, 1546, 1559, 1566(D), 1644, 1656, 1723, 1796, 1801, 1808.3,
29 1927, 1929, 1983, 1984, 2036, 2045, 2056, 2085, 2091, 2293, 2303
Page 5 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 164
SLS 19RS-347	ENGROSSED
1	*          *          *
2 Section 3.  R.S. 44:4.1(B)(11) as amended by Section 2 of Act 371 of the 2018
3 Regular Session is hereby amended and reenacted to read as follows:
4 §4.1. Exceptions
5	*          *          *
6	B. The legislature further recognizes that there exist exceptions, exemptions,
7 and limitations to the laws pertaining to public records throughout the revised
8 statutes and codes of this state. Therefore, the following exceptions, exemptions, and
9 limitations are hereby continued in effect by incorporation into this Chapter by
10 citation:
11	*          *          *
12	(11) R.S. 22:2, 14, 31, 42.1, 88, 244, 263, 265, 461, 550.7, 571, 572, 572.1,
13 574, 618, 639, 691.4, 691.5, 691.6, 691.7, 691.8, 691.9, 691.9.1, 691.10, 691.38,
14 691.56, 732, 752, 753, 771, 834, 972(D), 1008, 1019.2, 1203, 1260.44, 1460, 1464,
15 1466, 1488, 1546, 1559, 1566(D), 1644, 1656, 1657.1, 1723, 1796, 1801, 1808.3,
16 1927, 1929, 1983, 1984, 2036, 2045, 2056, 2085, 2091, 2293, 2303
17	*          *          *
18 Section 4.  R.S. 22:1657 and R.S. 22:1657 as amended by Section 1 of Act 371 of
19 the 2018 Regular Session are hereby repealed.
20 Section 5.  The provisions of Section 3 of this Act shall become effective on
21 January 1, 2020.
The original instrument was prepared by Christine Arbo Peck.  The following
digest, which does not constitute a part of the legislative instrument, was
prepared by Laura Gail Sullivan.
DIGEST
SB 164 Engrossed 2019 Regular Session	Morrish
Present law provides for regulation of prior authorization procedures for prescription drugs.
Proposed law retains present law and makes technical changes.
Present law requires insurers to provide certain override procedures for physicians when step
therapy or fail first protocols are utilized. Proposed law retains present law and adds a
process for exemption from step therapy for patients who have clinical documentation that
a prescription drug was discontinued due to lack of efficacy or effectiveness, diminished
effect, or an adverse event. Proposed law provides that a plan shall not be prevented from
Page 6 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 164
SLS 19RS-347	ENGROSSED
requiring a patient to try a generic drug. Proposed law provides that a practitioner shall not
be prevented from prescribing what he determines to be medically necessary.
Present law requires pharmacy benefit managers to be licensed by the commissioner of
insurance as third party administrators. Proposed law repeals present law and establishes
specific pharmacy benefit manager licensure and regulation authority for the commissioner
of insurance. Proposed law provides for findings and purpose, rulemaking, license authority,
and enforcement.
Present law prohibits pharmacy benefit managers from imposing contract provisions on
pharmacists that prevent the pharmacist from informing patients of all relevant options when
acquiring prescription drugs. Proposed law retains present law.
Present law establishes a dedicated location on the Department of Insurance's website for
certain information regarding pharmacy benefit managers. Present law implements the
website on January 1, 2020. Proposed law retains present law.
Effective August 1, 2019.
(Amends R.S. 22:1006.1(A) and 1053(D) and R.S. 44:4.1(B)(11) and 44:4.1(B) as amended
by Section 2 of Act 371 of the 2018 Regular Session; adds R.S. 22:1053(E) and (F), and
1260.41 - 1260.46; repeals R.S. 22:1657 and 1657 as amended by Section 1 of Act 371 of
the 2018 Regular Session)
Summary of Amendments Adopted by Senate
Committee Amendments Proposed by Senate Committee on Insurance to the original
bill
1. Makes technical changes.
Page 7 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.